Le Lézard
Classified in: Health
Subjects: MAV, CPG, CFG

/R E P E A T -- MEDIA ADVISORY - Minister Fraser to make an announcement regarding Express Entry for skilled newcomers in health care fields/


BEDFORD, NS, June 27, 2023 /CNW/ - The Honourable Sean Fraser, Minister of Immigration, Refugees and Citizenship, will be joined by the Honourable Jean-Yves Duclos, Minister of Health, to announce measures to address labour needs in the health care sector.

Minister Fraser and Minister Duclos will be joined by:

Date:

Wednesday, June 28, 2023

Location:

The Nova Scotia College of Nursing


300-120 Western Parkway


Bedford, Nova Scotia  B4B 0V2



Event 1 ? B-roll video footage (cameras only)

Time:

Setup at 10:45 a.m. Atlantic daylight time


Filming at 11:00 a.m. Atlantic daylight time



Event 2 ? Media availability

Time:

11:30 a.m. Atlantic daylight time


Notes for media:

SOURCE Immigration, Refugees and Citizenship Canada


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: